# Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia

> **NCT02232503** · — · COMPLETED · sponsor: **Novartis Slovakia, s.r.o.** · enrollment: 4011 (actual)

## Conditions studied

- Diabetic Retinopathy
- Diabetic Macular Edema
- Diabetes Mellitus

## Interventions

- **GENETIC:** Studied cohort

## Key facts

- **NCT ID:** NCT02232503
- **Lead sponsor:** Novartis Slovakia, s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 4011 (ACTUAL)
- **Last updated:** 2016-09-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02232503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02232503, "Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02232503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
